Market Analysis and Insights: Global Pharmacokinetics Services Market
The global Pharmacokinetics Services market size is projected to reach US$ 845.1 million by 2026, from US$ 641.4 million in 2020, at a CAGR of 4.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacokinetics Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacokinetics Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacokinetics Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacokinetics Services market.
Pharmacokinetics Services Breakdown Data by Type
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Pharmacokinetics Services Breakdown Data by Application
Small & Medium Enterprise
Large Enterprise
Based on regional and country-level analysis, the Pharmacokinetics Services market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmacokinetics Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
The global Pharmacokinetics Services market size is projected to reach US$ 845.1 million by 2026, from US$ 641.4 million in 2020, at a CAGR of 4.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacokinetics Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacokinetics Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacokinetics Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacokinetics Services market.
Pharmacokinetics Services Breakdown Data by Type
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Pharmacokinetics Services Breakdown Data by Application
Small & Medium Enterprise
Large Enterprise
Based on regional and country-level analysis, the Pharmacokinetics Services market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmacokinetics Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Small Molecules Pharmacokinetics Services
1.2.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Pharmacokinetics Services Market Share by Application: 2020 VS 2026
1.3.2 Small & Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Services Market Perspective (2015-2026)
2.2 Global Pharmacokinetics Services Growth Trends by Regions
2.2.1 Pharmacokinetics Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacokinetics Services Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacokinetics Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Services Players by Market Size
3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2015-2020)
3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2015-2020)
3.2 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
3.4 Global Pharmacokinetics Services Market Concentration Ratio
3.4.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2019
3.5 Key Players Pharmacokinetics Services Area Served
3.6 Key Players Pharmacokinetics Services Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Services Breakdown Data by Type (2015-2026)
4.1 Global Pharmacokinetics Services Historic Market Size by Type (2015-2020)
4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2021-2026)
5 Pharmacokinetics Services Breakdown Data by Application (2015-2026)
5.1 Global Pharmacokinetics Services Historic Market Size by Application (2015-2020)
5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmacokinetics Services Market Size (2015-2026)
6.2 North America Pharmacokinetics Services Market Size by Type (2015-2020)
6.3 North America Pharmacokinetics Services Market Size by Application (2015-2020)
6.4 North America Pharmacokinetics Services Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Pharmacokinetics Services Market Size (2015-2026)
7.2 Europe Pharmacokinetics Services Market Size by Type (2015-2020)
7.3 Europe Pharmacokinetics Services Market Size by Application (2015-2020)
7.4 Europe Pharmacokinetics Services Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Pharmacokinetics Services Market Size (2015-2026)
8.2 China Pharmacokinetics Services Market Size by Type (2015-2020)
8.3 China Pharmacokinetics Services Market Size by Application (2015-2020)
8.4 China Pharmacokinetics Services Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Pharmacokinetics Services Market Size (2015-2026)
9.2 Japan Pharmacokinetics Services Market Size by Type (2015-2020)
9.3 Japan Pharmacokinetics Services Market Size by Application (2015-2020)
9.4 Japan Pharmacokinetics Services Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Pharmacokinetics Services Market Size (2015-2026)
10.2 Southeast Asia Pharmacokinetics Services Market Size by Type (2015-2020)
10.3 Southeast Asia Pharmacokinetics Services Market Size by Application (2015-2020)
10.4 Southeast Asia Pharmacokinetics Services Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Evotec AG (Germany)
11.1.1 Evotec AG (Germany) Company Details
11.1.2 Evotec AG (Germany) Business Overview
11.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
11.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2015-2020))
11.1.5 Evotec AG (Germany) Recent Development
11.2 Pacific BioLabs (US)
11.2.1 Pacific BioLabs (US) Company Details
11.2.2 Pacific BioLabs (US) Business Overview
11.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
11.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.2.5 Pacific BioLabs (US) Recent Development
11.3 GVK Biosciences Private Limited (India)
11.3.1 GVK Biosciences Private Limited (India) Company Details
11.3.2 GVK Biosciences Private Limited (India) Business Overview
11.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
11.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2015-2020)
11.3.5 GVK Biosciences Private Limited (India) Recent Development
11.4 Shanghai Medicilon Inc. (China)
11.4.1 Shanghai Medicilon Inc. (China) Company Details
11.4.2 Shanghai Medicilon Inc. (China) Business Overview
11.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
11.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2015-2020)
11.4.5 Shanghai Medicilon Inc. (China) Recent Development
11.5 Pharmaceutical Product Development, LLC (US)
11.5.1 Pharmaceutical Product Development, LLC (US) Company Details
11.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
11.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
11.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
11.6 Charles River Laboratories International, Inc. (US)
11.6.1 Charles River Laboratories International, Inc. (US) Company Details
11.6.2 Charles River Laboratories International, Inc. (US) Business Overview
11.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
11.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.6.5 Charles River Laboratories International, Inc. (US) Recent Development
11.7 PAREXEL International Corporation (US)
11.7.1 PAREXEL International Corporation (US) Company Details
11.7.2 PAREXEL International Corporation (US) Business Overview
11.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
11.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.7.5 PAREXEL International Corporation (US) Recent Development
11.8 Eurofins Scientific, Inc. (Luxembourg)
11.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Details
11.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
11.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
11.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2015-2020)
11.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
11.9 Frontage Labs (US)
11.9.1 Frontage Labs (US) Company Details
11.9.2 Frontage Labs (US) Business Overview
11.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
11.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.9.5 Frontage Labs (US) Recent Development
11.10 SGS SA (Switzerland)
11.10.1 SGS SA (Switzerland) Company Details
11.10.2 SGS SA (Switzerland) Business Overview
11.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
11.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2015-2020)
11.10.5 SGS SA (Switzerland) Recent Development
11.11 LGC Limited (UK)
10.11.1 LGC Limited (UK) Company Details
10.11.2 LGC Limited (UK) Business Overview
10.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
10.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2015-2020)
10.11.5 LGC Limited (UK) Recent Development
11.12 Creative Bioarray (US)
10.12.1 Creative Bioarray (US) Company Details
10.12.2 Creative Bioarray (US) Business Overview
10.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
10.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2015-2020)
10.12.5 Creative Bioarray (US) Recent Development
11.13 Certara, L.P. (Germany)
10.13.1 Certara, L.P. (Germany) Company Details
10.13.2 Certara, L.P. (Germany) Business Overview
10.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
10.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2015-2020)
10.13.5 Certara, L.P. (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Small Molecules Pharmacokinetics Services
1.2.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Pharmacokinetics Services Market Share by Application: 2020 VS 2026
1.3.2 Small & Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Services Market Perspective (2015-2026)
2.2 Global Pharmacokinetics Services Growth Trends by Regions
2.2.1 Pharmacokinetics Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacokinetics Services Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacokinetics Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Services Players by Market Size
3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2015-2020)
3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2015-2020)
3.2 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
3.4 Global Pharmacokinetics Services Market Concentration Ratio
3.4.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2019
3.5 Key Players Pharmacokinetics Services Area Served
3.6 Key Players Pharmacokinetics Services Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Services Breakdown Data by Type (2015-2026)
4.1 Global Pharmacokinetics Services Historic Market Size by Type (2015-2020)
4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2021-2026)
5 Pharmacokinetics Services Breakdown Data by Application (2015-2026)
5.1 Global Pharmacokinetics Services Historic Market Size by Application (2015-2020)
5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmacokinetics Services Market Size (2015-2026)
6.2 North America Pharmacokinetics Services Market Size by Type (2015-2020)
6.3 North America Pharmacokinetics Services Market Size by Application (2015-2020)
6.4 North America Pharmacokinetics Services Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Pharmacokinetics Services Market Size (2015-2026)
7.2 Europe Pharmacokinetics Services Market Size by Type (2015-2020)
7.3 Europe Pharmacokinetics Services Market Size by Application (2015-2020)
7.4 Europe Pharmacokinetics Services Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Pharmacokinetics Services Market Size (2015-2026)
8.2 China Pharmacokinetics Services Market Size by Type (2015-2020)
8.3 China Pharmacokinetics Services Market Size by Application (2015-2020)
8.4 China Pharmacokinetics Services Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Pharmacokinetics Services Market Size (2015-2026)
9.2 Japan Pharmacokinetics Services Market Size by Type (2015-2020)
9.3 Japan Pharmacokinetics Services Market Size by Application (2015-2020)
9.4 Japan Pharmacokinetics Services Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Pharmacokinetics Services Market Size (2015-2026)
10.2 Southeast Asia Pharmacokinetics Services Market Size by Type (2015-2020)
10.3 Southeast Asia Pharmacokinetics Services Market Size by Application (2015-2020)
10.4 Southeast Asia Pharmacokinetics Services Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Evotec AG (Germany)
11.1.1 Evotec AG (Germany) Company Details
11.1.2 Evotec AG (Germany) Business Overview
11.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
11.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2015-2020))
11.1.5 Evotec AG (Germany) Recent Development
11.2 Pacific BioLabs (US)
11.2.1 Pacific BioLabs (US) Company Details
11.2.2 Pacific BioLabs (US) Business Overview
11.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
11.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.2.5 Pacific BioLabs (US) Recent Development
11.3 GVK Biosciences Private Limited (India)
11.3.1 GVK Biosciences Private Limited (India) Company Details
11.3.2 GVK Biosciences Private Limited (India) Business Overview
11.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
11.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2015-2020)
11.3.5 GVK Biosciences Private Limited (India) Recent Development
11.4 Shanghai Medicilon Inc. (China)
11.4.1 Shanghai Medicilon Inc. (China) Company Details
11.4.2 Shanghai Medicilon Inc. (China) Business Overview
11.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
11.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2015-2020)
11.4.5 Shanghai Medicilon Inc. (China) Recent Development
11.5 Pharmaceutical Product Development, LLC (US)
11.5.1 Pharmaceutical Product Development, LLC (US) Company Details
11.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
11.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
11.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
11.6 Charles River Laboratories International, Inc. (US)
11.6.1 Charles River Laboratories International, Inc. (US) Company Details
11.6.2 Charles River Laboratories International, Inc. (US) Business Overview
11.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
11.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.6.5 Charles River Laboratories International, Inc. (US) Recent Development
11.7 PAREXEL International Corporation (US)
11.7.1 PAREXEL International Corporation (US) Company Details
11.7.2 PAREXEL International Corporation (US) Business Overview
11.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
11.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.7.5 PAREXEL International Corporation (US) Recent Development
11.8 Eurofins Scientific, Inc. (Luxembourg)
11.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Details
11.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
11.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
11.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2015-2020)
11.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
11.9 Frontage Labs (US)
11.9.1 Frontage Labs (US) Company Details
11.9.2 Frontage Labs (US) Business Overview
11.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
11.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
11.9.5 Frontage Labs (US) Recent Development
11.10 SGS SA (Switzerland)
11.10.1 SGS SA (Switzerland) Company Details
11.10.2 SGS SA (Switzerland) Business Overview
11.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
11.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2015-2020)
11.10.5 SGS SA (Switzerland) Recent Development
11.11 LGC Limited (UK)
10.11.1 LGC Limited (UK) Company Details
10.11.2 LGC Limited (UK) Business Overview
10.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
10.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2015-2020)
10.11.5 LGC Limited (UK) Recent Development
11.12 Creative Bioarray (US)
10.12.1 Creative Bioarray (US) Company Details
10.12.2 Creative Bioarray (US) Business Overview
10.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
10.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2015-2020)
10.12.5 Creative Bioarray (US) Recent Development
11.13 Certara, L.P. (Germany)
10.13.1 Certara, L.P. (Germany) Company Details
10.13.2 Certara, L.P. (Germany) Business Overview
10.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
10.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2015-2020)
10.13.5 Certara, L.P. (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
